Acta Scientific Pharmaceutical Sciences

Research ArticleVolume 2 Issue 1

In Silico Antidiabetic Activity of Limonene Isolated from Coriandrum sativum Linn Fruit

M Padmaa Paarakh*

Department of Pharmacognosy, The Oxford College of Pharmacy, Bangalore, Karnataka, India

*Corresponding Author: M Padmaa Paarakh, Principal, Department of Pharmacognosy, The Oxford College of Pharmacy, Bangalore, Karnataka, India.

Received: December 20, 2017; Published: January 10, 2018

Citation: M Padmaa Paarakh. “In Silico Antidiabetic Activity of Limonene Isolated from Coriandrum sativum Linn Fruit”. Acta Scientific Pharmaceutical Sciences 2.1 (2018).

Abstract

Background and Aim: Diabetes mellitus [DM] is a metabolic disorder characterized by disturbances in carbohydrate, protein and lipid metabolism and by complications like micro vascular (retinopathy, neuropathy and nephropathy) and macro vascular (heart attack, stroke and peripheral vascular disease) complications. Coriandrum sativum Linn has been claimed to possess antidiabetic properties in Traditional System of Medicine. This study aimed to evaluate molecular interaction of limonene in C. sativum and targeted protein related to Type 2 DM.

Material and Methods: Isolation of Limonene from the methanol extract of fruit of C. sativum was done by column chromatography. Evaluation of hypoglycemic activity through an in silico docking approach with molecular target such as glutamine: fructose- 6-phosphate amidotransferase was performed. Molecular docking study was performed with Autodock docking software.

Results: The docking studies of the ligand limonene with target protein showed that this is a good inhibitor, which docks well related to diabetes mellitus with -1.57768 kJ mol-1 Van der waal energy and -17.6701 kJ mol-1 as docking energy. Hence limonene can be considered for developing into a potent anti-diabetic drug.

Conclusion: Management of diabetes is challenge to the medical treatment. This leads to increasing demand for natural products with antidiabetic activity with fewer side effects. This work establishes C. sativum extract as a potential inhibitor for diabetes. Thus enabling a possibility of this plant extract as a new alternative to existing diabetic treatment.

Keywords: Coriandrum sativum; Diabetes Mellitus; Molecular Docking; In Silico; Limonene

Copyright: © 2018 M Padmaa Paarakh. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.



Member In



News and Events


  • Special Issue on Reviews
    Acta Scientific Journals has been started Special Issue on Reviews, researchers from world wide welcoming for submission of their reviews on any topic by on/ before August 30, 2019. Special Issue is going to be released on September 10, 2019
  • Submission Timeline for Regular Issue
    Last date for submission of articles is August 30, 2019.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US